The global intranasal corticosteroids market size is calculated at USD 7.57 billion in 2025 and is expected to reach around ...
It is unclear if eye drops to reduce immune responses of the eye surface, such as topical corticosteroids and cyclosporine, have any effect on the signs and symptoms of blepharitis at 4 to 12 weeks.
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma A post hoc analysis was performed on individual patient data ...
Please provide your email address to receive an email when new articles are posted on . The International League of Dermatological Societies has released an updated position statement on the use of ...
Hilary Capell: rheumatologist whose research was grounded in the “complex realities of patient care”
When Hilary Capell became a consultant rheumatologist in 1978, at the age of just 29, there were very few options for ...
Thomas Jefferson University scientist Raymond Penn spends his days searching for the molecules that could be the key to better asthma treatments. He’s invested decades into this goal, for which stakes ...
The Cochrane Infectious Diseases Group (CIDG) have carried out a review update to evaluate the effects of corticosteroids being used alongside anti-tuberculosis medication to treat people suffering ...
Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...
A new study by researchers at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, has found that some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results